Scheel John R, Lee Janie M, Sprague Brian L, Lee Christoph I, Lehman Constance D
Department of Radiology, University of Washington, Seattle Cancer Care Alliance, Seattle, WA.
Department of Radiology, University of Washington, Seattle Cancer Care Alliance, Seattle, WA.
Am J Obstet Gynecol. 2015 Jan;212(1):9-17. doi: 10.1016/j.ajog.2014.06.048. Epub 2014 Jun 21.
There are potential benefits and harms of screening ultrasound (US) to supplement mammographic screening of women with dense breast tissue. We conducted a comprehensive literature review of studies assessing the efficacy of screening US to supplement mammography among women with dense breasts. From a total of 189 peer-reviewed publications on the performance of screening US, 12 studies were relevant to our analysis. The reporting of breast cancer risk factors varied across studies; however, the study populations tended to be at greater than average risk for developing breast cancer. Overall, US detected an additional 0.3-7.7 cancers per 1000 examinations (median, 4.2) and was associated with an additional 11.7-106.6 biopsies per 1000 examinations (median, 52.2). Significant improvements in cancer detection in dense breasts have been achieved with the transition from film to digital mammography. Thus adjunctive screening with ultrasound should be considered in the context of current screening mammography performance. Clinicians should discuss breast density as 1 of several important breast cancer risk factors, consider the potential harms of adjunctive screening, and arrive at a shared decision consistent with each woman's preferences and values.
对于乳腺组织致密的女性,采用超声筛查(US)辅助乳腺钼靶筛查存在潜在的益处和危害。我们对评估超声筛查辅助乳腺钼靶对乳腺致密女性有效性的研究进行了全面的文献综述。在总共189篇关于超声筛查性能的同行评审出版物中,有12项研究与我们的分析相关。各研究中乳腺癌风险因素的报告各不相同;然而,研究人群患乳腺癌的风险往往高于平均水平。总体而言,超声筛查每1000次检查额外检测出0.3 - 7.7例癌症(中位数为4.2),每1000次检查额外进行11.7 - 106.6次活检(中位数为52.2)。从胶片乳腺钼靶向数字乳腺钼靶转变后,致密乳腺中癌症检测有了显著改善。因此,应结合当前乳腺钼靶筛查的性能来考虑超声辅助筛查。临床医生应将乳腺密度作为几个重要的乳腺癌风险因素之一进行讨论,考虑辅助筛查的潜在危害,并根据每位女性的偏好和价值观达成共同决策。